Search research articles
Contact Us
Filters
Showing results (31-40 of 60) with videos related to
Page
of 6
Sort By:
AIDS Care
|
June 28, 2021
Cannabis use, pain interference, and prescription opioid receipt among persons with HIV: a target trial emulation study
William C Becker, Yu Li, Ellen C Caniglia, et al.
Journal of Clinical and Translational Science
|
May 21, 2026
Erratum: "Being treated as the expert:" A blueprint for a community advisory board approach to elevate the voice of people with living experience with substance use in academic research - ERRATUM
Trevor Moffitt, , Bryson Henson, et al.
Journal of Clinical and Translational Science
|
April 27, 2026
"Being treated as the expert:" A blueprint for a community advisory board approach to elevate the voice of people with living experience with substance use in academic research
Trevor Moffitt, , Bryson Henson, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 29, 2023
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
Stefania Chiappini, Rachel Vickers-Smith, Daniel Harris, et al.
Drug and Alcohol Dependence
|
September 6, 2021
Analysis of genetic and clinical factors associated with buprenorphine response
Richard C Crist, Rachel Vickers-Smith, Rachel L Kember, et al.
Journal of Addiction Medicine
|
April 10, 2024
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
Feitong Lei, Michelle R Lofwall, Jana McAninch, et al.
Alcoholism, Clinical and Experimental Research
|
March 8, 2022
Longitudinal analysis of the prevalence and correlates of heavy episodic drinking and self-reported opioid use among a national cohort of patients with HIV
Benjamin J Oldfield, Yu Li, Rachel Vickers-Smith, et al.
The American Journal of Psychiatry
|
June 7, 2023
Genetic Underpinnings of the Transition From Alcohol Consumption to Alcohol Use Disorder: Shared and Unique Genetic Architectures in a Cross-Ancestry Sample
Rachel L Kember, Rachel Vickers-Smith, Hang Zhou, et al.
Journal of Substance Use and Addiction Treatment
|
July 13, 2024
Corrigendum to "Development and validation of a community-level social determinants of health index for drug overdose deaths in the HEALing Communities Study" [Journal of Substance Use and Addiction Treatment (2024) 209186]
Nina Cesare, Lisa M Lines, Redonna Chandler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 6, 2025
Multi-ancestry genome-wide association meta-analysis of buprenorphine treatment response
Christal N Davis, Yousef Khan, Richard C Crist, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 60) with videos related to
Sort By:
Page
of 6
AIDS Care
|
June 28, 2021
Cannabis use, pain interference, and prescription opioid receipt among persons with HIV: a target trial emulation study
William C Becker, Yu Li, Ellen C Caniglia, et al.
Journal of Clinical and Translational Science
|
May 21, 2026
Erratum: "Being treated as the expert:" A blueprint for a community advisory board approach to elevate the voice of people with living experience with substance use in academic research - ERRATUM
Trevor Moffitt, , Bryson Henson, et al.
Journal of Clinical and Translational Science
|
April 27, 2026
"Being treated as the expert:" A blueprint for a community advisory board approach to elevate the voice of people with living experience with substance use in academic research
Trevor Moffitt, , Bryson Henson, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 29, 2023
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
Stefania Chiappini, Rachel Vickers-Smith, Daniel Harris, et al.
Drug and Alcohol Dependence
|
September 6, 2021
Analysis of genetic and clinical factors associated with buprenorphine response
Richard C Crist, Rachel Vickers-Smith, Rachel L Kember, et al.
Journal of Addiction Medicine
|
April 10, 2024
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
Feitong Lei, Michelle R Lofwall, Jana McAninch, et al.
Alcoholism, Clinical and Experimental Research
|
March 8, 2022
Longitudinal analysis of the prevalence and correlates of heavy episodic drinking and self-reported opioid use among a national cohort of patients with HIV
Benjamin J Oldfield, Yu Li, Rachel Vickers-Smith, et al.
The American Journal of Psychiatry
|
June 7, 2023
Genetic Underpinnings of the Transition From Alcohol Consumption to Alcohol Use Disorder: Shared and Unique Genetic Architectures in a Cross-Ancestry Sample
Rachel L Kember, Rachel Vickers-Smith, Hang Zhou, et al.
Journal of Substance Use and Addiction Treatment
|
July 13, 2024
Corrigendum to "Development and validation of a community-level social determinants of health index for drug overdose deaths in the HEALing Communities Study" [Journal of Substance Use and Addiction Treatment (2024) 209186]
Nina Cesare, Lisa M Lines, Redonna Chandler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 6, 2025
Multi-ancestry genome-wide association meta-analysis of buprenorphine treatment response
Christal N Davis, Yousef Khan, Richard C Crist, et al.
Page
of 6